Tag: Ovarian
Search News
Barts Cancer Institute teams awarded nearly £3m from Cancer Research UK to seek novel cancer therapy targets
11th March 2026
Professor Michelle Lockley and Dr Oliver Pearce have both been awarded prestigious Programme Foundation Awards from Cancer Research UK, worth nearly £1.5 million each, to support the work of their research groups at Barts Cancer Institute, Queen Mary University of London.
Read more
Smarter chemotherapy approach could delay drug resistance in ovarian cancer
30th April 2025
Adaptive chemotherapy can prolong survival in lab models of ovarian cancer, according to new results. The findings could pave the way for a more effective and gentler approach to treating ovarian cancer that uses existing drugs in a more intelligent way.
Read more
Scientists identify strategy to make chemotherapy more effective for women with ovarian cancer
7th March 2025
Scientists have discovered a potential way to improve chemotherapy’s effect on ovarian cancer by manipulating specific immune cells around the tumour, potentially offering a way to help thousands of women with ovarian cancer benefit more from standard therapies and potentially delay relapses.
Read more
Video: Engineering a Tumour on a Chip
29th August 2024
Meet Dr Joash Joy, a postdoctoral researcher working on engineering artificial tumours to explore how cancer therapies can be made more effective.
Read more
Video: Illuminating the city of cells inside cancer
6th July 2023
A new technique produces stunning, nebula-like images of tumours that provide crucial insights into cancer, how it behaves and how our immune cells attempt to fight it.
Read more
New insight into how a faulty protein drives lung cancer gives clues to why some therapies fail
15th June 2023
The findings could help explain why cancer drugs that target the molecule MET work for some people but not others.
Read more